Clinical Trials Browser

Phase EARLY_PHASE1 × Central Nervous System Neoplasms × Bevacizumab × Clear all

NCT03554707 2022-02-08

SGT-53 in Children With Recurrent or Progressive CNS Malignancies

Phase EARLY_PHASE1 Unknown

Central Nervous System Neoplasms